Study Reveals How Many Minutes You Should Walk Every Day To Avoid Back Pain
Researchers analysed over 11,000 participants aged 20 years or older in Norway over several years. The participants wore an accelerometer on their right thigh and lower back to measure how much they walked throughout the day and at what pace. Afterwards, chronic back pain was reported if any low back pain lasted more than three months.
The results showed that those walking between 78 and 100 minutes a day on average had a 13 per cent lower risk of developing chronic back pain than those who walked less than 78 minutes a day.
"Walking for more than 100 minutes per day was associated with a 23 per cent lower risk of chronic low back pain compared with walking less than 78 minutes per day," the study added.
Researchers said people who walked at a higher intensity also saw benefits, but these were less pronounced.
"Our findings suggest that daily walking volume is more important than mean walking intensity in reducing the risk of chronic lower back pain," it stated.
"These findings suggest that policies and public health strategies promoting walking could help to reduce the occurrence of chronic lower back pain."
Also Read | "Time To Leave": Frustrated By Bengaluru's Traffic, Man Decides To Move To...
The study findings are important as lower back pain has become an increasingly common ailment in individuals with a sedentary lifestyle, especially office goers who spend their days slumped over computers or in front of screens.
Gluteus medius tendinosis, commonly known as "dead butt syndrome," is a disorder marked by a weak or inactive gluteus medius muscle. It is frequently brought on by extended sitting, driving, or excessive screen time. Sluggish glutes can result in other muscles and joints, especially in the lower back and knees, picking up the slack
As per a 2022 study, the prevalence of low back pain in the Indian population was higher compared to global and other ethnic populations. The condition was more widespread in women, the rural population and elementary workers.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Wire
3 hours ago
- The Wire
Antibiotics, Diabetes and BP Drugs, Vitamin Supplements Found to Be Not of Standard Quality in June
Health Banjot Kaur Issues that Union and state regulators detected during their monthly inspections include contamination and incorrect labelling. Representative image of tablet drugs. Photo: New Delhi: Batches of as many as 185 drugs were found to be not of standard quality (NSQ) by Union and state drug regulators during their monthly inspection in June. The results of their inspections were released on Friday (July 18). A drug is labelled NSQ if it does not meet the quality standards laid down in the Indian laws governing drugs. The Central Drugs Standard Control Organisation (CDSCO) found batches of 55 drugs NSQ, with batches of the remaining 130 being flagged by various state drug regulators. The CDSCO is India's drug regulator at the Union government level. This is not a one-off list. It is a monthly document that the CDSCO publishes. The exercise became regular about a year ago. 'As part of the continuous regulatory surveillance, drug samples are picked from sales/distribution point and analysed, and the list of spurious [NSQ] drugs are displayed on the CDSCO portal on a monthly basis,' the CDSCO said. The purpose of displaying the list is to make stakeholders aware about the NSQ batches identified in the market, it added. The drugs that the CDSCO and state regulators most commonly found to be NSQ were mainly antibiotics, vitamin and calcium supplements, and anti-hypertensives (used for controlling blood pressure) in oral and injectable forms. The companies mentioned in this article are not the only ones whose products were found to be NSQ. We have only considered companies that made either multiple batches of a given drug that were found sub-par, or those that have manufactured various drugs that were found sub-par. It must be mentioned here that the CDSCO's and the states' labs only test a certain batch(es) of a particular medicine. If one batch of any drug has been red-flagged, it does not necessarily mean that all its batches would be substandard. Common 'errors' One of the most serious risks associated with NSQ drugs is improper sterility. This means that the drug contains harmful microorganisms that can lead to infection in a patient's body after ingestion. This could potentially cause extremely serious complications in patients, like sepsis or even death due to acute infection. The other common problem that some drugs have is that they contain 'particulate matter' – particles that inadvertently enter the drug during the manufacturing process. These particles can contaminate the drug. A 'description' error is one in which a drug's physical appearance does not match its prescribed appearance as per regulation. For example, if a tablet is described in regulation as having a white colour but a patient finds it to be orange, the tablet would have a description error. Several medicines were reported as experiencing 'loss on drying'. This error reflects the lack of moisture in drugs, which may cause microbial growth in them, potentially causing infection if ingested. A drug is labelled as having assay errors when an ingredient in it is found in a quantity that is higher or lower than what is mentioned on its label. A higher amount would mean an overdose and a lower amount would result in an underdose – the latter would lead to a situation where a patient even after consuming the prescribed strength of a drug ends up ingesting a lower quantity of some ingredient. This can lead to their disease getting worse. 'Extractable volume' errors usually occur with vials. If the liquid that is to be extracted from a vial using a syringe is present in a quantity greater or lower than as labelled, this can again lead to an overdose or underdose of the drug given in injectable form. 'Dissolution' errors can adversely affect the absorption of a drug. What did the CDSCO find? Six drugs manufactured by Paksons Pharmaceuticals Private Limited were found to be NSQ. These include a dexamethasone sodium phosphate injection – an antibiotic; an ascorbic acid injection, used as a vitamin C supplement; an adrenaline bitartrate injection, used during cardiac arrest; an ondansetron injection, used for treating nausea caused by cancer medicines; and a gentamicin injection, used for treating bacterial injections. The company's diclofenac sodium injection, used as a pain killer, had extractable volume issues in its vials. Four batches of Phaex Polymers Private Limited's colestyramine (used to treat high cholesterol) and three batches of its sodium polystyrene sulfonate (for regulating potassium levels) reported 'loss of drying' mistakes. Zee Laboratories' tranexamic acid injection, used for controlling excessive loss of blood during surgery in patients suffering from hemophilia, reported assay problems. On the other hand, its glipizide & metformin tablets, used for treating high blood sugar, had a description error. Two batches of Overseas Health Care Pvt Ltd's calcium aspartate, calcium orotate, calcitriol minerals and vitamin tablets, which are used to supplement calcium and micronutrients like zinc and vitamins to treat deficiencies, had compromised assays for almost all of their ingredients. Martin & Brown BioSciences Pvt Ltd's calcium gluconate injection had particulate matter and description errors along with extractable volume issues. Three batches of its rabeprazole sodium injection – used to treat acid reflux – also had particulate matter and assay problems. Two batches of E.G. Pharmaceuticals' vitamin C injection and vitamin B12, folic acid and niacinamide injection had particulate matter and description errors. Two batches of Healers Lab's telmisartan tablets (used to manage blood pressure) had dissolution issues. What did state drug regulators find? State drug regulators too found serious errors in some drugs. Five batches of Puniska Injectables's sodium chloride injection had serious sterility problems. These injections have multiple purposes. They are primarily given in cases of dehydration to restore electrolytes (sodium and chlorine). Similarly, Paschim Banga's dextrose injection, which is used to normalise blood sugar levels, and its sodium chloride injection, had sterility issues. Thirteen batches of Martin & Brown BioSciences' calcium and vitamin D3 tablets had description errors. Vivek Pharmachem's paracetamol and ciprofloxacin hydrochloride tablets had description and dissolution issues respectively. Safe Care Life Sciences's mecobalamin 2,500 mg injection, which is used for vitamin B12 supplementation, had 2.38 mg per ml of mecobalamin against the labelled claim of 2,500 mg per ml in its vial. Two batches of Oscar Remedies's ciprofloxacin & dexamethasone eye/ear drops had 943.33% more ciprofloxacin than the labelled amount. The full lists of NSQ drugs made by the CDSCO and state regulators can be found here and here respectively. The Wire is now on WhatsApp. Follow our channel for sharp analysis and opinions on the latest developments.
News18
4 hours ago
- News18
You Can Now Download Your Child's Vaccine History: Here's How
Last Updated: India's digital health mission is expanding, and U-WIN is a cornerstone of that effort. It brings everyday healthcare especially for children into the digital age. For years, Indian parents have clutched onto paper vaccination booklets, faded, handwritten, sometimes coffee-stained. They hope it won't be lost before school admissions or international travel. But in the background, a quiet revolution is unfolding. India is now rolling out digital vaccination records for children through a new platform called U-WIN, modelled on the success of the CoWIN system used during the COVID-19 pandemic. This could mean the end of missed doses, lost records, and confusion during hospital visits. What Is U-WIN and Why It Matters U-WIN stands for Universal Immunisation Platform, a project by the Union Health Ministry designed to track every vaccine given to children from birth to adolescence. It is being gradually introduced across several districts in states like Maharashtra, Uttar Pradesh, Tamil Nadu, and Kerala. Once fully implemented, U-WIN will allow parents to: If you're in a district where U-WIN has been activated, here's what to expect: When your child is vaccinated at a government health facility, the nurse or health worker logs the details into the U-WIN system. You then receive an SMS confirmation with a unique ID. Using that ID or your linked ABHA health account you can access the digital record anytime. Over time, this data will be available through a secure health portal, where parents can view and download certificates just like COVID vaccination slips. What If There's a Mistake? Errors can be corrected. If a vaccine dose wasn't recorded properly or your child's name or date of birth appears wrong, you can return to the health facility where the entry was made. The staff there can update it in the system, typically within a few days. Carry your original vaccination card or hospital slip for verification. The Private Hospital Question Currently, most U-WIN entries are from government health centres. But several private hospitals in cities like Bengaluru, Chennai, and Mumbai are already part of the pilot. If your child was vaccinated at a private clinic, you can ask if they're connected to U-WIN. Even if not, you'll be able to upload scanned proof once full integration begins. Why This Change Is Important This isn't just about convenience. A digital vaccination record helps during: Most importantly, it offers peace of mind. No more digging through drawers or calling old hospitals to trace lost records. U-WIN gives parents an official, reliable, lifelong record of their child's early health. The Future Is Paperless, Even in Healthcare India's digital health mission is expanding, and U-WIN is a cornerstone of that effort. It brings everyday healthcare especially for children into the digital age. For parents, it means fewer worries. For children, it means better protection. And for a country this vast, it's one less thing to lose in the chaos of daily life. view comments First Published: July 18, 2025, 17:00 IST News lifestyle » health-and-fitness You Can Now Download Your Child's Vaccine History: Here's How Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Time of India
6 hours ago
- Time of India
PU offers 1-year PG diplomas for agamic studies, rock art
Puducherry: Pondicherry University (PU) has established two research centres offering one-year postgraduate diploma courses in agamic studies and rock art. The Centre for Agamic Studies and Indian Knowledge Systems aims to study the dynamic role of temples in medieval Indian society. The centre would also study the role of agamic texts in the growth and expansion of the professional arts and crafts among the lower sections of society. A statement from the university said that agamic texts help unravel their role as contributors to sustainable development in medieval times, which can provide lessons in implementation of sustainable development goals in contemporary times. You Can Also Check: Chennai AQI | Weather in Chennai | Bank Holidays in Chennai | Public Holidays in Chennai The Centre for Rock Art and Cognitive Studies, a field-based course, will be a tribute to the temple culture of South India, which is vibrant and thriving, said the statement. The centre will focus on the evolution of cognitive capabilities of the human species and their manifestation in the form of paintings and engravings, it added. Both centres are part of the university's department of history. Pondicherry University vice-chancellor P Prakash Babu said the courses offer exciting avenues for the young generation to explore the fascinating world of agamic temple culture, encompassing the entire gamut of contemporary society. "The programme will equip the students with the necessary skills to get employed in eco-tourism, adventure tourism, as well as making them qualified site managers of the rock art locations," said the statement.
